Our results suggest that hyperactivation of the PI3K/AKT signaling pathway resulting from PTEN inactivation due to an inactivating mutation may regulate Prox1 expression in follicular carcinoma-originating FTC-133 cells. The gene discussed is PTEN; the disease is thyroid gland follicular carcinoma.